ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,386Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 51

$1.07M Total Retail Price of All Prescriptions

Rank: 10 out of 51

1,014 Patients Receiving at Least One Drug in Part D
48%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

35% of this provider’s 1,014 patients filled at least one prescription for a schedule three drug, compared to an average of 27%.

Risky Drugs to Seniors

4% of this provider’s 16,565 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 1,381 833 1 4
HYDROCODONE-ACETAMINOPHEN 1,295 400 S3 2 1
METFORMIN HCL 898 508 3 9
TRAMADOL HCL 870 290 4 10
AMLODIPINE BESYLATE 852 559 5 5
OMEPRAZOLE 820 430 6 3
FUROSEMIDE 769 586 7 2
POTASSIUM CHLORIDE 700 430 8 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 633 327 9 35
CARVEDILOL 621 461 10 13
LISINOPRIL 619 402 11 7
ACETAMINOPHEN-CODEINE 555 210 S3 12 96
LEVOTHYROXINE SODIUM 515 289 13 6
MELOXICAM 510 352 14 20
HYDROCHLOROTHIAZIDE 459 256 15 15
GLIPIZIDE 424 242 16 40
AMITRIPTYLINE HCL 417 122 R 17 49
CRESTOR 403 202 18 46
GABAPENTIN 388 140 19 12
FAMOTIDINE 372 142 20 55
ATENOLOL 336 188 21 33
VERAPAMIL ER 329 166 22 115
NAPROXEN SODIUM 322 146 10 23 189
CLONIDINE HCL 273 124 24 26
LOSARTAN POTASSIUM 257 165 25 29
AZITHROMYCIN 246 105 26 47
WARFARIN SODIUM 244 154 27 11
CIPROFLOXACIN HCL 241 144 28 48
PRAVASTATIN SODIUM 240 152 29 19
IBUPROFEN 233 59 30 93
TRIAMTERENE-HCTZ 231 107 31 80
ZOLPIDEM TARTRATE 229 76 32 22
INDOMETHACIN 228 160 R 10 33 213
KLOR-CON M20 222 144 34 83
ALLOPURINOL 221 152 35 43
LEVOCETIRIZINE DIHYDROCHLORIDE 220 82 36 199
PRENATAL PLUS 211 150 37 188
FLUTICASONE PROPIONATE 210 102 38 51
METOPROLOL TARTRATE 206 124 39 14
CYCLOBENZAPRINE HCL 203 42 R 40 53
PREDNISONE 200 81 41 76
DILTIAZEM 24HR CD 199 110 42 106
ATORVASTATIN CALCIUM 195 157 43 30
NEXIUM 193 81 44 24
INSULIN SYRINGE 191 107 45 134
DILTIAZEM 24HR ER 191 121 45 176
COLCRYS 186 133 47 143
ACTOS 182 111 48 138
CYPROHEPTADINE HCL 179 107 R 10 49 203
ADVAIR DISKUS 175 102 50 72
PROAIR HFA 174 78 51 63
DIGOXIN 171 111 52 42
ENALAPRIL MALEATE 162 85 53 81
LOSARTAN-HYDROCHLOROTHIAZIDE 160 96 54 66
LYRICA 158 66 55 54
DIOVAN HCT 158 74 55 131
HYDRALAZINE HCL 156 89 57 52
TRAZODONE HCL 156 102 57 23
MUPIROCIN 149 102 59 141
PANTOPRAZOLE SODIUM 149 94 59 34
HUMULIN 70-30 139 76 61 104
CLOPIDOGREL 134 106 62 41
SPIRONOLACTONE 123 80 63 68
GLIPIZIDE ER 119 98 64 122
PHENYTOIN SODIUM EXTENDED 117 34 65 84
PROMETHAZINE HCL 115 53 R 66 56
DIOVAN 114 98 67 70
AMOX TR-POTASSIUM CLAVULANATE 112 45 68 182
MINOXIDIL 111 69 69 251
LACTULOSE 110 62 70 121
SULFAMETHOXAZOLE-TRIMETHOPRIM 109 44 71 62
FLUOXETINE HCL 109 13 71 60
SPIRIVA 105 80 73 87
RANITIDINE HCL 103 70 74 28
PAROXETINE HCL 101 55 75 69
AMLODIPINE BESYLATE-BENAZEPRIL 101 85 75 117
PLAVIX 98 79 77 58
METOPROLOL SUCCINATE 97 36 78 25
NAMENDA 94 94 79 16
GLIMEPIRIDE 94 57 79 71
DONEPEZIL HCL 94 91 79 17
DILTIAZEM ER 93 53 82 179
TAMSULOSIN HCL 89 65 83 36
ESCITALOPRAM OXALATE 89 54 83 39
CELEBREX 87 59 85 129
MECLIZINE HCL 86 68 86 103
BENICAR 85 45 87 237
SERTRALINE HCL 85 40 87 32
ISOSORBIDE MONONITRATE ER 84 67 89 57
GLYBURIDE 82 53 R 90 119
VENTOLIN HFA 79 37 91 171
METOCLOPRAMIDE HCL 79 32 91 64
ALENDRONATE SODIUM 77 65 93 59
PIOGLITAZONE HCL 74 49 R 94 268
NAPROXEN 73 20 95 120
CEPHALEXIN 70 40 96 67
CITALOPRAM HBR 70 36 96 18
FENOFIBRATE 69 46 98 160
HYDROXYZINE HCL 68 13 R 99 99
PREMARIN 67 0 R 100 149
LEVETIRACETAM 65 24 101 61
PEN NEEDLE 65 43 101 202
LANTUS 64 30 103 31
POLYETHYLENE GLYCOL 3350 64 32 103 45
NIFEDIPINE ER 62 18 105 186
FOSINOPRIL SODIUM 59 59 106 292
ZETIA 59 31 106 153
MEGESTROL ACETATE 59 58 R 106 88
TRICOR 59 26 106 167
CLINDAMYCIN HCL 57 27 110 251
QUINAPRIL HCL 57 41 110 152
ISOSORBIDE DINITRATE 55 37 112 228
NOVOLIN 70-30 54 41 113 89
ROPINIROLE HCL 53 40 114 75
FLUCONAZOLE 52 15 115 128
BYSTOLIC 51 51 116 161
TRIAMCINOLONE ACETONIDE 51 19 116 140
TRAVATAN Z 50 34 118 162
DEXAMETHASONE SODIUM PHOSPHATE 50 47 118 314
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.